Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant (Q24247000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

title

Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

1 reference

1 reference

recurrent miscarriage

1 reference

1 reference

M Empson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Lassere

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Craig

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Scott

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

18 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

CD002859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Pregnancy outcome in women with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Prevention of fetal death in the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: Preconception versus postconception treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Update on the management of the pregnant patient with antiphospholipid antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Antiphospholipid antibodies: biological basis and prospects for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Antiplatelet agents for preventing pre-eclampsia and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Low-molecular-weight heparins in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

An evidence based approach to individualising treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Lupus anticoagulant and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002859.PUB2

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

21 January 2018

1 reference

12 December 2020

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

12 December 2020

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

1 reference

12 December 2020

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

1 reference

12 December 2020

Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment

1 reference

12 December 2020

Prevention of miscarriage in antiphospholipid syndrome

1 reference

12 December 2020

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

12 December 2020

Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome

1 reference

12 December 2020

Recurrent abortion and moderate or strong antiphospholipid antibody production

1 reference

12 December 2020

Low molecular weight heparin as thromboprophylaxis throughout pregnancy in heritable thrombophilic women.

1 reference

12 December 2020

Immunosuppressive therapy for recurrent aborters with positive antiphospholipid antibodies and alteration of 6ketoPGF1 alpha/TXB2 ratio

1 reference

12 December 2020

The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization

1 reference

12 December 2020

Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: results of a pilot study

1 reference

12 December 2020

Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases

1 reference

12 December 2020

Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy

1 reference

12 December 2020

Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study

1 reference

12 December 2020

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

1 reference

12 December 2020

Effect of prednisone and heparin treatment in 14 patients with poor reproductive efficiency related to lupus anticoagulant

1 reference

12 December 2020

Antiphospholipid syndrome in obstetrics

1 reference

12 December 2020

Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials

1 reference

12 December 2020

Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin

1 reference

12 December 2020

Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy

1 reference

12 December 2020

Prevention of early pregnancy loss in autoantibody seropositive women

1 reference

12 December 2020

Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin

1 reference

12 December 2020

Antiphospholipid antibodies and pregnancy

1 reference

12 December 2020

Anticardiolipin antibodies in patients with recurrent pregnancy wastage: treatment and uterine blood flow.

1 reference

12 December 2020

Antiphospholipid antibodies in pregnancy

1 reference

12 December 2020

Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies.

1 reference

12 December 2020

Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin

1 reference

12 December 2020

Treatment of Patients With Antiphospholipid Antibodies During Pregnancy

1 reference

12 December 2020

Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies

1 reference

12 December 2020

Clinical observation on effect of Chinese herbal medicine plus human chorionic gonadotropin and progesterone in treating anticardiolipin antibody-positive early recurrent spontaneous abortion

1 reference

12 December 2020

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin

1 reference

12 December 2020

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome

1 reference

12 December 2020

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

12 December 2020

Repeated fetal losses and the lupus anticoagulant

1 reference

12 December 2020

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

12 December 2020

Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss

1 reference

12 December 2020

Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome

1 reference

12 December 2020

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group

1 reference

12 December 2020

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

1 reference

12 December 2020

High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin

1 reference

12 December 2020

Low-dose aspirin in pregnancy

1 reference

12 December 2020

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion

1 reference

12 December 2020

Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy

1 reference

12 December 2020

Habitual abortions in 678 healthy patients: investigation and prevention

1 reference

12 December 2020

Obstetric outcome in antiphospholipid syndrome

1 reference

12 December 2020

Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production

1 reference

12 December 2020

Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death

1 reference

12 December 2020

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

12 December 2020

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

12 December 2020

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

12 December 2020

Placental pathology and antiphospholipid antibodies: a descriptive study

1 reference

12 December 2020

Antiphospholipid antibodies, infertility and recurrent miscarriage

1 reference

12 December 2020

Anti-cardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in patients with recurrent fetal miscarriage

1 reference

12 December 2020

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience

1 reference

12 December 2020

A study of sixty pregnancies in patients with the antiphospholipid syndrome.

1 reference

12 December 2020

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

12 December 2020

A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin

1 reference

12 December 2020

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

12 December 2020

Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes

1 reference

12 December 2020

Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study Group

1 reference

12 December 2020

Low molecular weight heparin for obstetric thromboprophylaxis.

1 reference

12 December 2020

Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity

1 reference

12 December 2020

Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates

1 reference

12 December 2020

Bone density studies in pregnant women receiving heparin

1 reference

12 December 2020

A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss

1 reference

12 December 2020

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

1 reference

12 December 2020

The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies

1 reference

12 December 2020

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

12 December 2020

Recurrent miscarriage--an aspirin a day?

1 reference

12 December 2020

10.1002/14651858.CD002859.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2754748

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

11 January 2020

2754748

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846641%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

15846641

1 reference